Evaluating nipocalimab for the treatment of chronic inflammatory demyelinating polyneuropathy

  • Published on 05/29/2026
  •  Reading time: 1 min.

Kazumoto Shibuya a,* , Kazuaki Kito a , Tomoki Suichi a , Sonoko Misawa a,b & Satoshi Kuwabara a

a Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan
b Department of Neurology, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan

CONTACT Kazumoto Shibuya mailto:kazumoto@net.email.ne.jp Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba 260-8670, Japan

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Rare Diseases

Receive our newsletter to stay up to date with the latest news in Rare Diseases